Cipla has informed that the board of directors of the company at its meeting held on February 06, 2013, has decided to issue 10,00,000 stock options to Subhanu Saxena, chief executive officer subject to requisite approvals. The options would be granted to Subhanu Saxena by the compensation committee on mutually acceptable terms.
The company is seeking approval of shareholders to the aforesaid proposal by means of postal ballot and has appointed B. Narasimhan, Practising company secretary as scrutinizer for conducting the postal ballot process.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: